Hale Therapeutics

📍 Philadelphia, United States🗓 Founded 2019👥 14 employees💰 Last funded Jan 2020
Hale has built a low-harm, low-risk digital drug therapy device for nicotine de-addiction.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2019
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Hale Therapeutics?
Hale Therapeutics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Hale Therapeutics last raise funding?
The most recent investment in Hale Therapeutics recorded on gritt.io was in January 2020.
When was Hale Therapeutics founded?
Hale Therapeutics was founded in 2019.
What industry is Hale Therapeutics in?
Hale Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Hale Therapeutics based?
Hale Therapeutics is headquartered in Philadelphia, United States.